DECIBEL CANNABIS CO INC (DB.CA) Stock Fundamental Analysis
Canada - TSX-V:DB - CA2434371001 - Common Stock
0.13 CAD
-0.01 (-7.14%)
We assign a fundamental rating of 4 out of 10 to DB. DB was compared to 31 industry peers in the Pharmaceuticals industry. While DB is still in line with the averages on profitability rating, there are concerns on its financial health. DB is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year DB has reported negative net income.
In the past year DB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DB reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: DB reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.31%, DB belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
The Return On Equity of DB (19.17%) is better than 93.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.31% | ||
| ROE | 19.17% | ||
| ROIC | N/A |
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 12.36%, DB belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
In the last couple of years the Profit Margin of DB has grown nicely.
With a Gross Margin value of 26.97%, DB is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
DB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 12.36% | ||
| GM | 26.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
2. Health
2.1 Basic Checks
DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
DB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DB has more shares outstanding
The debt/assets ratio for DB has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.09, we must say that DB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.09, DB is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
The Debt to FCF ratio of DB is 17.10, which is on the high side as it means it would take DB, 17.10 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DB (17.10) is better than 70.97% of its industry peers.
DB has a Debt/Equity ratio of 0.54. This is a neutral value indicating DB is somewhat dependend on debt financing.
DB has a worse Debt to Equity ratio (0.54) than 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 17.1 | ||
| Altman-Z | 1.09 |
ROIC/WACCN/A
WACC7.54%
2.3 Liquidity
DB has a Current Ratio of 1.35. This is a normal value and indicates that DB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.35, DB is doing worse than 67.74% of the companies in the same industry.
DB has a Quick Ratio of 1.35. This is a bad value and indicates that DB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.56, DB is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
DB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.00%, which is quite impressive.
DB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 90.70% yearly.
Looking at the last year, DB shows a decrease in Revenue. The Revenue has decreased by -0.53% in the last year.
Measured over the past years, DB shows a very strong growth in Revenue. The Revenue has been growing by 71.51% on average per year.
EPS 1Y (TTM)70%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%2800%
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%34.67%
3.2 Future
The Earnings Per Share is expected to grow by 77.26% on average over the next years. This is a very strong growth
Based on estimates for the next years, DB will show a quite strong growth in Revenue. The Revenue will grow by 13.17% on average per year.
EPS Next Y227.5%
EPS Next 2Y119.2%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue Next Year28.61%
Revenue Next 2Y24.25%
Revenue Next 3Y20.73%
Revenue Next 5Y13.17%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Forward Earnings ratio of 4.63, the valuation of DB can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DB indicates a rather cheap valuation: DB is cheaper than 96.77% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DB to the average of the S&P500 Index (31.86), we can say DB is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 4.63 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DB indicates a somewhat cheap valuation: DB is cheaper than 64.52% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.92 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DB's earnings are expected to grow with 77.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y119.2%
EPS Next 3Y77.26%
5. Dividend
5.1 Amount
DB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:DB (11/6/2025, 7:00:00 PM)
0.13
-0.01 (-7.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.03%
Ins Owner ChangeN/A
Market Cap74.99M
Revenue(TTM)100.50M
Net Income(TTM)12.42M
Analysts82
Price Target0.27 (107.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-13.84%
Max Revenue beat(2)7.97%
Revenue beat(4)2
Avg Revenue beat(4)-2.44%
Min Revenue beat(4)-13.84%
Max Revenue beat(4)7.97%
Revenue beat(8)2
Avg Revenue beat(8)-5.71%
Revenue beat(12)5
Avg Revenue beat(12)0.01%
Revenue beat(16)5
Avg Revenue beat(16)-0.97%
PT rev (1m)0%
PT rev (3m)6.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-53.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 4.63 | ||
| P/S | 0.75 | ||
| P/FCF | 27.92 | ||
| P/OCF | 18.33 | ||
| P/B | 1.16 | ||
| P/tB | 1.17 | ||
| EV/EBITDA | N/A |
EPS(TTM)0
EYN/A
EPS(NY)0.03
Fwd EY21.58%
FCF(TTM)0
FCFY3.58%
OCF(TTM)0.01
OCFY5.46%
SpS0.17
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.31% | ||
| ROE | 19.17% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 12.36% | ||
| GM | 26.97% | ||
| FCFM | 2.67% |
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 17.1 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 23.79% | ||
| Cap/Sales | 1.4% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 21.63% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 1.09 |
F-Score5
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)70.46%
Cap/Depr(5y)95.47%
Cap/Sales(3y)2.65%
Cap/Sales(5y)5.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%2800%
EPS Next Y227.5%
EPS Next 2Y119.2%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%34.67%
Revenue Next Year28.61%
Revenue Next 2Y24.25%
Revenue Next 3Y20.73%
Revenue Next 5Y13.17%
EBIT growth 1Y-131.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year316.38%
EBIT Next 3Y86.96%
EBIT Next 5Y48.36%
FCF growth 1Y-33.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.23%
OCF growth 3YN/A
OCF growth 5YN/A
DECIBEL CANNABIS CO INC / DB.CA FAQ
What is the ChartMill fundamental rating of DECIBEL CANNABIS CO INC (DB.CA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to DB.CA.
Can you provide the valuation status for DECIBEL CANNABIS CO INC?
ChartMill assigns a valuation rating of 5 / 10 to DECIBEL CANNABIS CO INC (DB.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for DECIBEL CANNABIS CO INC?
DECIBEL CANNABIS CO INC (DB.CA) has a profitability rating of 4 / 10.